Drug Shortage Report for TEGRETOL
| Report ID | 98249 |
| Drug Identification Number | 00010405 |
| Brand name | TEGRETOL 200MG |
| Common or Proper name | TEGRETOL 200MG TABS 100'S |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100'S |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-06 |
| Estimated end date | 2019-12-19 |
| Actual end date | 2019-12-18 |
| Shortage status | Resolved |
| Updated date | 2019-12-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-12-19 | French | Compare |
| v5 | 2019-12-19 | English | Compare |
| v4 | 2019-12-02 | French | Compare |
| v3 | 2019-12-02 | English | Compare |
| v2 | 2019-11-08 | French | Compare |
| v1 | 2019-11-08 | English | Compare |
Showing 1 to 6 of 6